| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3980241 | Cancer Treatment Reviews | 2010 | 6 Pages |
Abstract
SummaryThe Epstein-Barr virus (EBV) is a lymphotropic herpes virus with oncogenetic properties which can lead to the development of lymphomas such as Burkitt’s lymphoma (BL), Hodgkin’s lymphoma (HL), or post-transplant lymphoma. This review discusses our current understanding of lymphomagenesis in relation to EBV and the potential for targeted therapies.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Fathima Zumla Cader, Pamela Kearns, Lawrence Young, Paul Murray, Martina Vockerodt,